RNA Seq Market Projected to Reach $2.65 Billion to 2022 | Outlook, Trends & Analysis

The global NGS-based RNA-seq market is projected to reach USD 2.65 Billion by 2022 from USD 1.05 Billion in 2017, at a CAGR of 20.2% during the forecast period.

Request for sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=1024407

The advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-Seq grants, increasing number of research activities, and rapid growth in precision medicine are the key factors driving the growth of the market. On the other hand, lack of skilled professionals and standardization concerns of RNA-seq in diagnostic testing are some of the key factors limiting the growth of the market. The increasing applications of RNA-seq in research are expected to provide a wide range of growth opportunities for players in the market. Storage and interpretation of sequencing data and analysis of RNA-seq data for novel transcripts are expected to challenge market growth.
The major players in the global market are
1. Illumina, Inc. (U.S.),
2. Thermo Fisher Scientific Inc. (U.S.),
3. QIAGEN N. V. (Germany),
4. Pacific Biosciences of California, Inc. (U.S.),
5. BGI (China),
6. Oxford Nanopore Technologies, Ltd. (U.K.),
7. PerkinElmer, Inc. (U.S.),
8. GATC Biotech AG (Germany),
9. Agilent Technologies, Inc. (U.S.),
10. Roche Holding AG (Switzerland),
11. Macrogen, Inc. (South Korea),
12. Eurofins Scientific (Luxembourg).

In 2016, the sequencing platforms and consumables segment is expected to account for the largest share of the market. The data analysis, storage, and management is expected to register the highest growth rate owing to its development of more efficient data analysis solutions and growing computational capabilities of data analytics providers.

Browse complete report on NGS-based RNA-seq Market by Products & Services (Sample Preparation, Consumables, Bioinformatics), Technology (SBS, SMRT), Application (De novo, Transcriptome Epigenetics, Small RNA), End User (Research Centers, BioPharma Companies) - Global Forecast to 2022 with 153 pages, 42 tables and 45 figures , now available at
http://www.rnrmarketresearch.com/ngs-based-rna-seq-market-by-products-services-sample-preparation-consumables-bioinformatics-technology-sbs-smrt-application-de-novo-transcriptome-epigenetics-small-rna-end-user-research-centers-bio-st-to-2022-market-report.html

Research centers and academic & government institutes segment accounted for the largest share of the global market in 2016 due to the increasing focus of market players on providing efficient RNA-seq products & services for research applications and the growing number of government funding programs. However, the hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. Based on applications, the market is categorized into four segments, namely, de novo transcriptome assembly, expression profiling analysis, variant calling & transcriptome epigenetics, and small RNA sequencing. The expression profiling analysis segment accounted for the major share of the global NGS-based RNA-seq market owing to the technological advantages of expression profiling applications.

Access complete research paper on NGS-based RNA-seq Market @ http://www.rnrmarketresearch.com/contacts/purchase?rname=1024407

On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Thermo Fisher Scientific and Children's Hospital Los Angeles (CHLA, U.S.) collaborated to develop a targeted RNA & DNA sequencing-based research gene-panel specifically for pediatric cancer.

RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:
Ritesh Tiwari
2nd floor, Metropole,
Next to Inox theatre, Bund garden road,
Pune-411001
Maharashtra, India.
sales@rnrmarketresearch.com

This release was published on openPR.